Newswire

Vote withdraws 11 letters, reports supporting PBMs Industry group argues pharmacy benefit market is ‘dynamic’ Bloomberg Law The FTC voted...

Policy from 2000s put PBMs in ‘regulatory free zone’ Push for oversight of the companies heats up Bloomberg Law The FTC on Thursday plans...

After years of buying and closing competitors, CVS understaffing leads to chaos and delays, Ohio regulator says Ohio Capitol Journal At...

American Economic Liberties Project During the first half of an oversight hearing in the House Judiciary Committee today, a bipartisan...

STAT News Reporters: Casey Ross and Bob Herman Frustration was boiling into open conflict within NaviHealth, a company that uses computer...

Modern Healthcare Reporter: LAUREN BERRYMAN Yet another congressional committee has advanced legislation aimed at bringing down...

STAT+ Employers across the country — from big names like Boeing and UPS to local school systems — pay consulting firms to handle a...

Real Clear Health More than 7 million US citizens depend on insulin to live, but more than 16 percent of Americans, are rationing their...

Vanderbilt’s Stacie Dusetzina and colleagues explain how the ‘copay adjustment’ programs work in this week’s JAMA Internal Medicine and...

Inside Health Policy The group representing state insurance commissioners is seeking information from the Justice Department and Federal...

The New York Times The Times reported last month that drug shortages in the United States are approaching record levels, with thousands...

Lawmakers began regulating pharmacy benefit managers in 2015, but the state has never issued an enforcement action The Lund Report Every...

The Washington Examiner Members of both parties on the House Committee on Oversight and Accountability expressed support for the...

Drug pricing: Antitrust regulator to probe shadowy purchasing organizations Ohio Capital Journal The Federal Trade Commission on...

Washington Post Opinion Author: Elisabeth Rosenthal Millions of Americans in the past few years have run into this experience: filing a...

Round of subpoenas is the latest attempt to pierce industry Entities allow PBMs to ‘hide the ball,’ consultant says Bloomberg US...

KFF Health News Under the leadership of an aggressive opponent of anti-competitive business practices, the Federal Trade Commission is...

Over the last five years, both PBMs and drug manufacturers have implemented restrictions that put more of the costs for specialty...

Axios Pro A Congressional panel unanimously advanced legislation with new transparency requirements for pharmacy benefit managers on...

Ohio Capital Journal The prescriptions with the most eye-popping price tags — like cancer meds that can cost more than $20,000 a month —...